Chabha Benyahia
Paris, 75018, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Downregulation of PGI2 pathway in Pulmonary Hypertension Group-III patients.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: February 15, 2020
Bronchodilation induced by PGE2 is impaired in Group III pulmonary hypertension.
Journal: British journal of pharmacology
Published: May 16, 2019
Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients.
Journal: Prostaglandins & other lipid mediators
Published: April 30, 2019
Prostanoid EP₂ Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells.
Journal: International journal of molecular sciences
Published: July 18, 2018
Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractile agents.
Journal: Prostaglandins & other lipid mediators
Published: March 16, 2015
Control of human vascular tone by prostanoids derived from perivascular adipose tissue.
Journal: Prostaglandins & other lipid mediators
Published: January 04, 2013
A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Journal: Prostaglandins & other lipid mediators
Published: December 21, 2012
Absence of inflammatory conditions in human varicose saphenous veins.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: August 07, 2012
Prostaglandin E2 receptor subtypes in human blood and vascular cells.
Journal: European journal of pharmacology
Published: April 06, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026